What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?

Area of Science:

• Immunology
• Genetics
• Hepatology

Background:

• Chronic hepatitis C virus (HCV) infection leads to liver cirrhosis and cancer.
• Genome-wide association studies (GWAS) identified genetic variants in the interferon lambda (IFN-λ) region linked to HCV clearance.
• The IFNL4 gene, discovered in 2013, explains these GWAS findings, with the IFNL4-ΔG/TT variant (rs368234815) regulating IFN-λ4 protein production.

Purpose of the Study:

• To investigate the paradoxical association between IFNL4 variants and HCV clearance.
• To explore the implications of these findings on the established understanding of interferon's antiviral functions.
• To examine the role of IFN-λ genetic variants in hepatic inflammation and fibrosis.

Main Methods:

• Analysis of genome-wide association studies (GWAS) data.
• Functional investigation of the IFNL4 gene and its variants.
• Correlation analysis of IFNL4 alleles with HCV clearance rates and treatment responses.
• Examination of associations between IFN-λ region variants and liver inflammation/fibrosis.

Main Results:

• The IFNL4-TT allele, which prevents IFN-λ4 production, is paradoxically linked to higher spontaneous HCV clearance and better treatment outcomes.
• This finding challenges the conventional view of interferons (IFNs) as solely antiviral cytokines.
• Conversely, alleles associated with improved HCV clearance correlate with increased hepatic inflammation and fibrosis.

Conclusions:

• The IFNL4-TT "knock-out" allele enhances HCV clearance, questioning the paradigm of IFNs as purely antiviral.
• GWAS in infectious diseases can uncover significant and unanticipated biological mechanisms.
• Understanding these genetic influences is crucial for managing HCV and other liver diseases.